Biotechnology News

Thu, 2013-11-14 22:00

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) today announced that it has completed its previously announced private placement of $750 million aggregate principal amount of its convertible senior notes, including notes...

Thu, 2013-11-14 17:00

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ: IIN), today announced financial results for its third quarter ended September 30, 2013.

Thu, 2013-11-14 17:00

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--The RNS(R) System has been granted premarket approval (PMA) from the FDA for the treatment of adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.

Thu, 2013-11-14 17:00

ZURICH & VIENNA--(BUSINESS WIRE)--The 19th annual BIO-Europe® international partnering conference held last week in Vienna, Austria, reported record attendance.

Thu, 2013-11-14 17:00

PARIS--(BUSINESS WIRE)--Regulatory News : BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, today published the major key...

Thu, 2013-11-14 17:00

FREMONT, Calif.--(BUSINESS WIRE)--OnCore Manufacturing Launches OnCore Interconnect Business Adding Cable and Harness products To Their Offering

Thu, 2013-11-14 17:00

PARIS--(BUSINESS WIRE)--Regulatory News : Mauna Kea Technologies (Paris:MKEA) (NYSE Euronext: MKEA FR0010609263), leader in the optical biopsy market and maker of Cellvizio, the fastest way to see cancer, today announced that physicians around...

Thu, 2013-11-14 17:00

MEMPHIS, Tenn.--(BUSINESS WIRE)--CirQuest expands predictive laboratory analytic capability for evaluation of genetic variation in drug development/drug metabolism plus a wide range of pharmacogenomic and toxicogenomics applications.

Thu, 2013-11-14 12:00

CINCINNATI--(BUSINESS WIRE)--Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the worldwide release of the MyTaqTM Blood-PCR Kit, developed for fast, highly-specific PCR direct...

Thu, 2013-11-14 12:00

WALTHAM, Mass.--(BUSINESS WIRE)--Histogenics Corporation, a late stage company focused on regenerative medicine technologies, today announced that John H. Johnson has been appointed to the company's board of directors. Mr. Johnson is currently...

Thu, 2013-11-14 12:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--A novel predictive diagnostic technology that discriminates leukemia patient response to therapy will be presented at ASH Annual Meeting 2013. Outcomes and biomarker status suggest clinical utility.

Thu, 2013-11-14 12:00

DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation today filed its fiscal quarter Form 10-Q and reported financial results and disclosed record operating results for the quarter ended September 30, 2013.

Thu, 2013-11-14 12:00

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced an exclusive promotion and marketing agreement with LEO Pharma for detailing OTREXUP™ (methotrexate) to dermatologists for symptomatic control of severe...

Thu, 2013-11-14 12:00

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced...

Thu, 2013-11-14 12:00

ALPHARETTA, Ga. & HALIFAX, Nova Scotia--(BUSINESS WIRE)--Cartiva, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced the signing of a distribution agreement with foot and ankle...

Thu, 2013-11-14 12:00

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Foundation Marks World Diabetes Day with Four Grants Addressing Link Between Diabetes, Depression and Distress

Thu, 2013-11-14 12:00

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ:TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that Dr. Stephen A. Hill, President and Chief Executive Officer, is scheduled to...

Thu, 2013-11-14 12:00

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc (NYSE MKT: FCSC) announces financial results for the third quarter ended September 30, 2013 and provides an update on recent business developments.

Thu, 2013-11-14 12:00

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (OTCQB:RTRX) today announced that it has appointed Jeffrey Paley, MD to its Board of Directors, effective November 15, 2013. This latest appointment brings the Company’s Board to five members. Commenting...

Thu, 2013-11-14 12:00

FT. LAUDERDALE, Fla.--(BUSINESS WIRE)--Puget Technologies’ (OTCBB: PUGE) subsidiary, Cannabis Biotech, continues to explore delivery options for medical marijuana to appeal to alternative markets such as women and seniors.

Thu, 2013-11-14 12:00

DUBLIN, Ohio--(BUSINESS WIRE)--A new patent covering the formulation of Navidea's radiolabeled dopamine transporter ligand, NAV5001, used with SPECT imaging for potential diagnosis of Parkinsonian Syndrome and DLB was issued.

Thu, 2013-11-14 12:00

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that Wyeth LLC, its wholly owned subsidiary, has notified The Bank of New York Mellon, as trustee under the applicable indenture, of its election to fully redeem all of its...

Thu, 2013-11-14 12:00

WALTHAM, Mass.--(BUSINESS WIRE)--Blood banks are essential links in the healthcare supply chain around the globe. Thermo Fisher Scientific recently installed its 1000th blood banking centrifuge in India at the All India Institute of Medical...

Thu, 2013-11-14 12:00

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today reported financial results for the quarter ended September 30, 2013. “The third quarter of 2013 was a productive one for us,” said Guy Macdonald, Tetraphase...

Thu, 2013-11-14 12:00

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The report addresses clinical, design, and operational considerations for pediatric diabetes clinical trials.

Thu, 2013-11-14 12:00

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN) a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer is providing a quarterly update today on its three clinical...

Thu, 2013-11-14 12:00

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--Gore enrolls first patient in iliac branch study.

Thu, 2013-11-14 12:00

BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc. presented preclinical data at the Society for Immunotherapy of Cancer (SITC) annual meeting in National Harbor, Maryland on Saturday, November 9th on the development of synthetic derivatives...

Thu, 2013-11-14 12:00

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE:AZN) today announced plans to conduct two new clinical studies as part of PARTHENON, AstraZeneca’s largest clinical trial program involving over 80,000 patients. The studies are designed to...

Thu, 2013-11-14 12:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell...

Thu, 2013-11-14 12:00

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics (NASDAQ: OXBT) announces closing of Phyxius Pharma Levosimendan acquisition. John Kelley Appointed CEO of Oxygen Biotherapeutics.

Thu, 2013-11-14 12:00

NEW PROVIDENCE, N.J.--(BUSINESS WIRE)--Svelte® Medical Systems today announced enrollment of the final patient in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug Carrier Technology) clinical study. DIRECT II...

Thu, 2013-11-14 12:00

SAN FRANCISCO--(BUSINESS WIRE)--Breakout Labs, Peter Thiel's philanthropic revolving investment fund for early-stage cutting edge scientific research celebrates its 2nd year anniversary funding two new grantees.

Thu, 2013-11-14 12:00

HOUSTON--(BUSINESS WIRE)--DNAtrix a biotech focusing on oncolytic viruses, announced today that the first patient was treated with the company’s DNX-2401 product in combination with temozolomide in a Phase I study for patients

Thu, 2013-11-14 12:00

MANSFIELD, Mass.--(BUSINESS WIRE)--Coleman N. Lannum, Vice President, Investor Relations, Covidien, will present at the Jefferies 2013 Global Healthcare Conference in London on November 21, 2013 at 10:00AM local time (5:00AM ET).

Thu, 2013-11-14 07:01

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: To the shareholders of DiaGenic ASA (OSE:DIAG). Reference is made to the announcement on 1 November 2013 regarding the Extraordinary General Meeting in DiaGenic ASA to elect members to the board of...

Thu, 2013-11-14 07:01

PLANEGG, Germany--(BUSINESS WIRE)--Biomax Informatics AG will invest nearly 1 million Euro over the next 4 years to provide knowledge management for mental health research studying links between psychotic disorders and metabolism.

Thu, 2013-11-14 07:01

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: RaySearch Laboratories AB (STO:RAYB) announces that the first patient in China has been treated with a treatment plan created with RaySearch’s treatment planning system RayStation®. The treatment was...

Thu, 2013-11-14 02:02

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eli and Edythe Broad to invest an additional $100 million into the Broad Institute to launch a new decade of transformative work to harness recent biomedical discoveries to benefit patients.

Thu, 2013-11-14 02:02

WALTHAM, Mass.--(BUSINESS WIRE)--Avedro to commercialize the only device to accurately measure corneal biomechanical strength pre-and post-Lasik surgery

Wed, 2013-11-13 20:00

LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma announces Third Quarter 2013 financial results. Year-over-year 41% gross revenue increase and a gross profit increase of 84% for the nine months ended September 30, 2013.

Wed, 2013-11-13 20:00

TRENTON, N.J.--(BUSINESS WIRE)--Focusing on the patient needs, BioNJ’s 2104 Annual Meeting will feature NFL legend and patient advocate for spinal cord injuries Nick Buoniconti as a Keynote Speaker on Jan. 30, 2104.

Wed, 2013-11-13 20:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScience Reports Third Quarter Fiscal 2013 Financial Results

Wed, 2013-11-13 20:00

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Announces Changes in Senior Management Team

Wed, 2013-11-13 15:00

HARRISBURG, Pa.--(BUSINESS WIRE)--The Pennsylvania Senate Public Health and Welfare Committee introduced legislation to notify patients & physicians of changes to prescriptions.

Wed, 2013-11-13 15:00

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Pete Yonkman today is named president of Cook Medical, the world's largest privately owned medical device company.

Wed, 2013-11-13 15:00

MINNEAPOLIS--(BUSINESS WIRE)--Starkey Hearing Technologies, one of the world’s leading hearing technology companies, today announced that it has been named an International CES Innovations 2014 Design and Engineering Awards Honoree for Xino™...